A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Clinical trial NCT06625671 · RECRUITING

Trial details

NCT number: NCT06625671
Sponsor: DualityBio Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

Start date: 2024-10-04
Primary completion: 2027-06-30
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.